These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 26101226)

  • 41. Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
    T A M; Chng R; Yau WP
    Ann Transplant; 2021 Dec; 26():e933588. PubMed ID: 34963678
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Generic cyclosporine: a word of caution.
    Ponticelli C
    J Nephrol; 2004; 17 Suppl 8():S20-4. PubMed ID: 15599881
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tacrolimus: a further update of its use in the management of organ transplantation.
    Scott LJ; McKeage K; Keam SJ; Plosker GL
    Drugs; 2003; 63(12):1247-97. PubMed ID: 12790696
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Single-center, open, prospective, randomized pilot study comparing cyclosporine versus tacrolimus in simultaneous pancreas-kidney transplantation.
    Boggi U; Vistoli F; Del Chiaro M; Croce C; Morelli L; Coletti L; Signori S; Giannarelli R; Marchetti P; Del Prato S; Rizzo G; Mosca F
    Transplant Proc; 2004 May; 36(4):1064-6. PubMed ID: 15194369
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunosuppressive regimens containing generic mycophenolate mofetil (Myfenax) in de novo renal transplant recipients--preliminary results of 6-month observation.
    Rutkowski B; Bzoma B; Dębska-Ślizień A; Chamienia A
    Ann Transplant; 2011; 16(4):74-80. PubMed ID: 22210425
    [TBL] [Abstract][Full Text] [Related]  

  • 46. De novo use of a generic formulation of tacrolimus versus reference tacrolimus in kidney transplantation: evaluation of the clinical results, histology in protocol biopsies, and immunological monitoring.
    Melilli E; Crespo E; Sandoval D; Manonelles A; Sala N; Mast R; Padulles A; Grinyo JM; Bestard O; Cruzado JM
    Transpl Int; 2015 Nov; 28(11):1283-90. PubMed ID: 26088437
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Consensus statement of the Croatian Society for Nephrology, Dialysis and Transplantation regarding the use of generic immunosuppressive drugs].
    Bašić-Jukić N; Rački S; Knotek M; Bubić-Filipi L; Bubić I; Zibar L; Kes P;
    Acta Med Croatica; 2014 Apr; 68(2):211-4. PubMed ID: 26012162
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevention of early acute rejection with daclizumab and triple immunosuppression in cadaveric renal allograft recipients.
    Kandus A; Grego K; Bren AF
    Ther Apher Dial; 2005 Jun; 9(3):262-4. PubMed ID: 15967003
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of Mycophenolate Mofetil Dose Reduction on Allograft Outcomes in Kidney Transplant Recipients on Tacrolimus-Based Regimens: A Systematic Review.
    Su VCh; Greanya ED; Ensom MH
    Ann Pharmacother; 2011 Feb; 45(2):248-57. PubMed ID: 21304036
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A single center's clinical experience with quadruple immunosuppression including ATG or IL2 antibodies and mycophenolate mofetil in simultaneous pancreas-kidney transplants.
    Hesse UJ; Troisi R; Jacobs B; Van Vlem B; de Hemptinne B; Van Holder R; Vermassen F; De Roose J; Lameire N
    Clin Transplant; 2000 Aug; 14(4 Pt 1):340-4. PubMed ID: 10945205
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
    Nashan B
    Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The use of generics in transplantation: Towards rational and safe solutions!].
    Rottembourg J; Rostoker G
    Presse Med; 2018 Mar; 47(3):199-210. PubMed ID: 29555162
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interleukin-2 receptor monoclonal antibodies in renal transplantation: meta-analysis of randomised trials.
    Adu D; Cockwell P; Ives NJ; Shaw J; Wheatley K
    BMJ; 2003 Apr; 326(7393):789. PubMed ID: 12689974
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Organ Procurement and Transplantation Network/Scientific Registry of Transplant Recipients 2014 Data Report: Intestine.
    Cai J; Wu G; Qing A; Everly M; Cheng E; Terasaki P
    Clin Transpl; 2014; ():33-47. PubMed ID: 26281125
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunosuppressants for the prophylaxis of corneal graft rejection after penetrating keratoplasty.
    Abudou M; Wu T; Evans JR; Chen X
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007603. PubMed ID: 26313245
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Steroid avoidance or withdrawal for kidney transplant recipients.
    Pascual J; Zamora J; Galeano C; Royuela A; Quereda C
    Cochrane Database Syst Rev; 2009 Jan; (1):CD005632. PubMed ID: 19160257
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A pilot study of immunosuppressive monotherapy in liver transplantation: tacrolimus versus microemulsified cyclosporin.
    Rolles K; Davidson BR; Burroughs AK
    Transplantation; 1999 Oct; 68(8):1195-8. PubMed ID: 10551650
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation.
    Johnson C; Ahsan N; Gonwa T; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; van Veldhuisen P; Salm K; Tolzman D; Fitzsimmons WE
    Transplantation; 2000 Mar; 69(5):834-41. PubMed ID: 10755536
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Generics in transplantation medicine: Randomized comparison of innovator and substitution products containing mycophenolate mofetil
.
    Reigner B; Grange S; Bentley D; Banken L; Abt M; Hughes R; Scheubel E; Guentert TW
    Int J Clin Pharmacol Ther; 2019 Oct; 57(10):506-519. PubMed ID: 31397274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.